U Pozzetto

Summary

Publications

  1. ncbi Balance of transforming growth factor-beta1 and platelet-derived growth factor-BB is associated with kidney allograft rejection
    Ubaldo Pozzetto
    Centro Shock, IASI CNR, Largo Gemelli 8, 00168 Rome, Italy
    Ann Clin Biochem 45:213-4. 2008
  2. ncbi RGDS peptide inhibits activation of lymphocytes and adhesion of activated lymphocytes to human umbilical vein endothelial cells in vitro
    Ubaldo Pozzetto
    Laboratory of Immunology, Shock Center, Iasi, CNR, Rome, Italy
    Immunol Cell Biol 83:25-32. 2005
  3. ncbi Dyslipidemia can reduce the immunosuppressive effects of cyclosporine
    U Pozzetto
    Shock Center, Iasi, CNR, Roma, Italy
    Transpl Immunol 18:349-51. 2008
  4. ncbi Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens
    F Citterio
    Department of Surgery, Division of Organ Transplantation, Catholic University Sacred Heart, Rome, Italy
    Transplant Proc 36:698-9. 2004
  5. ncbi Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients
    U Pozzetto
    C.N.R, Centro per la Fisiopatologia dello Shock, c/o Policlinico A. Gemelli, Catholic University of the Sacred Heart, L. 60 F. Vito 1, 00168 Rome, Italy
    Transplant Proc 34:1740-2. 2002
  6. ncbi Long-term predictive value of cyclosporine microemulsion C2 level for chronic renal allograft dysfunction
    F Citterio
    Department of Surgery, Division of Organ Transplantation, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy
    Transplant Proc 35:2894-8. 2003
  7. ncbi Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients
    F Citterlo
    Department of Surgery, Division of Organ Transplantation, Catholic University, Rome, Italy
    Transplant Proc 35:1292-4. 2003
  8. ncbi Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up
    F Citterio
    Division of Organ Transplantation, Department of Surgery, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy
    Transplant Proc 34:1685-6. 2002
  9. ncbi HHV8 in renal transplant recipients
    A Diociaiuti
    Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy
    Transpl Int 13:S410-2. 2000
  10. ncbi Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups
    Diego Serraino
    Virology Section, University Campus Bio Medico, Spallanzani Hospital, Rome, Italy
    Methods Mol Biol 471:409-19. 2009

Collaborators

  • G Nanni
  • F Citterio
  • J Romagnoli
  • Antonio Facchiano
  • F Citterlo
  • P Cattani
  • Enrico Scala
  • P Burra
  • Diego Serraino
  • Marco Galli
  • A Diociaiuti
  • A Buda
  • E De Juli
  • G Rezza
  • A Arbustini
  • C Pradier
  • M Grasso
  • B Longo
  • Pierluca Piselli
  • B Dal Bello
  • M Dorrucci
  • G Busnach
  • M P Carrieri
  • U Baccarrani
  • Giuseppe Tringali
  • Giacomo Pozzoli
  • Mauro Vairano
  • Pierluigi Navarra
  • Gianluca Falcone
  • Vincenzo De Santis
  • Caterina Toriani Terenzi
  • M Capuano
  • D Cerimele
  • C Masini
  • I Lesnoni la Parola
  • M Castagneto
  • G Fadda

Detail Information

Publications11

  1. ncbi Balance of transforming growth factor-beta1 and platelet-derived growth factor-BB is associated with kidney allograft rejection
    Ubaldo Pozzetto
    Centro Shock, IASI CNR, Largo Gemelli 8, 00168 Rome, Italy
    Ann Clin Biochem 45:213-4. 2008
    ....
  2. ncbi RGDS peptide inhibits activation of lymphocytes and adhesion of activated lymphocytes to human umbilical vein endothelial cells in vitro
    Ubaldo Pozzetto
    Laboratory of Immunology, Shock Center, Iasi, CNR, Rome, Italy
    Immunol Cell Biol 83:25-32. 2005
    ..These data suggest a potential role of RGDS in cell-mediated immunity, inflammation and organ transplantation...
  3. ncbi Dyslipidemia can reduce the immunosuppressive effects of cyclosporine
    U Pozzetto
    Shock Center, Iasi, CNR, Roma, Italy
    Transpl Immunol 18:349-51. 2008
    ..Few data are available on the effects of dyslipidemia on the immunosuppressive action of immunosuppressive agents. We investigate the in vitro effects of lipids solution on the immunosuppressive action of cyclosporine (CsA)...
  4. ncbi Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens
    F Citterio
    Department of Surgery, Division of Organ Transplantation, Catholic University Sacred Heart, Rome, Italy
    Transplant Proc 36:698-9. 2004
    ..Follow-up studies seek to assess the possible relationship with clinical events...
  5. ncbi Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients
    U Pozzetto
    C.N.R, Centro per la Fisiopatologia dello Shock, c/o Policlinico A. Gemelli, Catholic University of the Sacred Heart, L. 60 F. Vito 1, 00168 Rome, Italy
    Transplant Proc 34:1740-2. 2002
  6. ncbi Long-term predictive value of cyclosporine microemulsion C2 level for chronic renal allograft dysfunction
    F Citterio
    Department of Surgery, Division of Organ Transplantation, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy
    Transplant Proc 35:2894-8. 2003
    ..C(2) values above 900 ng/mL are appropriate to minimize the risk of CRAD among patients receiving cyclosporine microemulsion and steroids...
  7. ncbi Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients
    F Citterlo
    Department of Surgery, Division of Organ Transplantation, Catholic University, Rome, Italy
    Transplant Proc 35:1292-4. 2003
    ..Short-term amelioration of the renal function is best obtained when early conversion is performed. Long-term follow-up will be necessary to confirm these preliminary data...
  8. ncbi Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up
    F Citterio
    Division of Organ Transplantation, Department of Surgery, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy
    Transplant Proc 34:1685-6. 2002
  9. ncbi HHV8 in renal transplant recipients
    A Diociaiuti
    Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy
    Transpl Int 13:S410-2. 2000
    ..Our data suggest that being positive for HHV8 before transplantation could be an important risk factor for the development of KS...
  10. ncbi Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups
    Diego Serraino
    Virology Section, University Campus Bio Medico, Spallanzani Hospital, Rome, Italy
    Methods Mol Biol 471:409-19. 2009
    ..In this chapter, the use of this methodologic approach in southern Europe is illustrated and limitations are discussed...
  11. ncbi Metallic but not ceramic wear particles increase prostaglandin E2 release and interleukin-1beta gene expression in human blood monocytes in vitro
    Marco Galli
    Institute of Orthopedics, Catholic University School of Medicine, 00168 Rome, Italy
    Int J Mol Med 18:141-5. 2006
    ..The lower activity of alumina compared to metals suggests that the former should be preferred in implants for its favorable biological and mechanical behavior...